KAT6A and osteoporosis: We also discovered that angelicin dose-dependently increased KAT6A expression and that this increase in turn helped activate the Nrf2/HO-1 antioxidant stress system and ameliorate bone mass loss in oophorectomy-induced osteoporosis model rats by decreasing intracellular ROS levels.